This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2018-2022.
Company Filing History:
Years Active: 2018-2022
Title: Thomas C Smyrk: Innovator in Cancer Risk Assessment
Introduction
Thomas C Smyrk is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in assessing cancer risk among patients with inflammatory bowel disease. With a total of 2 patents, Smyrk's work is pivotal in advancing cancer detection methodologies.
Latest Patents
Smyrk's latest patents focus on materials and methods for determining cancer risk. One of his key documents relates to assessing inflammatory bowel disease patients at risk for developing cancer. Specifically, it provides materials and methods for monitoring colorectal cancer risk in patients suffering from ulcerative colitis. This innovative approach aims to enhance early detection and improve patient outcomes.
Career Highlights
Thomas C Smyrk is affiliated with the Mayo Foundation for Medical Education and Research, where he applies his expertise in medical research. His work is instrumental in developing strategies that can potentially save lives by identifying cancer risks early in patients with inflammatory bowel disease.
Collaborations
Smyrk collaborates with esteemed colleagues in his field, including Edward V Loftus, Jr and William J Sandborn. These partnerships enhance the research efforts and contribute to the overall success of their projects.
Conclusion
In summary, Thomas C Smyrk is a dedicated inventor whose work in cancer risk assessment is making a significant impact in the medical field. His innovative patents and collaborations are paving the way for improved patient care and outcomes.